Skroot

Executive Summary

Skroot Laboratory, based in Ames, Iowa, develops the SMART Platform, a contact-free, real-time monitoring system for cell culture using single-use resonant sensors. Founded in 2015, the company addresses key challenges in biomanufacturing and cell therapy by enabling label-free, non-optical tracking of cell growth. This technology reduces contamination risks and optimizes production processes, offering a scalable solution for the growing cell and gene therapy market. While Skroot operates in a competitive landscape, its proprietary sensors and focus on real-time, non-invasive monitoring differentiate it from traditional optical methods. As the biomanufacturing sector increasingly adopts process analytical technology (PAT), Skroot's platform is well-positioned to gain traction. The company remains private with no disclosed funding or revenue, suggesting a need for commercialization partnerships or additional capital to scale.

Upcoming Catalysts (preview)

• TBDCommercial partnership with a major cell therapy manufacturer65% success
• TBDSeries A funding round to scale production and sales70% success
• TBDLaunch of next-generation sensor with enhanced sensitivity55% success